Antibody titers of individuals vaccinated for COVID-19: A systematic review-Reference-Cited by-同舟云学术

Antibody titers of individuals vaccinated for COVID-19: A systematic review

Published:2023-09-02 Issue:3 Volume:48 Page:
ISSN:0973-7138
Container-title:Journal of Biosciences
language:en
Short-container-title:J Biosci

Author:

Domado Aminoddin M,Adaza Homobono Jacob F,Beltran Andrea Pauline Nicole C,Buenviaje Leila M,Co Catherine D,Combalicer Leira R,Corona Shiela May A,Cruz John Benedict F,Dinjotian Maria Adrianne Camille G,Esperanzate Eli Marie S,Luna Shaira Reinalyn G,Pascua Ethelbert Justine R,Vicencio Richard Rupert T,Reyes Sherwin N^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12038-023-00355-1.pdf

Reference125 articles.

1. Ahmed TI, Rishi S, Irshad S, et al. 2022 Inactivated vaccine Covaxin/BBV152: A systematic review. Front. Immunol. 13 863162

2. Angyal A, Longet S, Moore SC, et al. 2022 T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study. Lancet Microbe 3 e21–e31

3. Assawakosri S, Kanokudom S, Suntronwong N, et al. 2022 Neutralizing activities against the omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination. J. Infect. Dis. 10 jiac092

4. Atmar RL, Lyke KE, Deming ME, et al. 2021 Heterologous SARS-CoV-2 booster vaccinations - preliminary report. medRxiv https://doi.org/10.1101/2021.10.10.21264827

5. Bar-On Y, Goldberg Y, Mandel M, et al. 2021 Protection against Covid-19 by BNT162b2 booster across age groups. N. Engl. J. Med. 385 2421–2430